Replies to post #208209 on Biotech Values

[poorgradstudent]

CD47/SIRP:

Are you suggesting there are concerns now about the viability of targeting SIRP-CD47 in general?

No, I'd say make of it what you will. I just thought it was germane to a recurring topic on this board, and may even have had a small impact on recent share price.